Results 41 to 50 of about 2,906,730 (289)
Frontiers in Oncology, 2018 BackgroundCell-free DNA (cfDNA) can be detected in the circulation of healthy individuals, but is found in higher concentrations in cancer patients. Furthermore, mutations in tumor cells can be identified in circulating DNA fragments.
Jonathan M. Fussey +9 more
doaj +1 more source
Serum and Urinary Matrix Metalloproteinase-9 Concentrations in Dehydrated Horses
Animals, 2023 Matrix metalloproteinase-9 is increased in renal tissue in human kidney disease, but its role as a biomarker for kidney disease has not been fully evaluated yet.
Julia N. van Spijk +6 more
doaj +1 more source
Validation of a blood plasma separation system by biomarker detection [PDF]
, 2010 A microfluidic system was developed for blood plasma separation at high flow rate. This system uses only hydrodynamic forces to separate plasma from whole blood.
Campbell, Colin J. +4 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Characterizing stressful events reported by childhood cancer survivors experienced throughout the lifespan may help improve trauma‐informed care relevant to the survivor experience. Methods Participants included 2552 survivors (54% female; 34 years of age) and 469 community controls (62% female; 33 years of age) from the St.
Megan E. Ware +13 more
wiley +1 more source
HRT-Net: A Cell-free Cooperative Sensing Method Based on Attention-weighted Hierarchical Network
Leida xuebaoThis paper proposes an intelligent framework based on a cell-free network architecture, called HRT-Net. HRT-Net is designed to enhance multi-station collaborative sensing problems for Dual-Functional Radar-Communication (DFRC) systems, offering accurate ...
Shengheng LIU +5 more
doaj +1 more source
Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies [PDF]
, 2015 Objectives To report clinical implementation of cell‐free DNA (cfDNA) analysis of maternal blood in screening for trisomies 21, 18 and 13 in twin pregnancies and examine variables that could influence the failure rate of the test.
BEVILACQUA, ELISA +7 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Neuroblastoma is the most common extracranial solid tumor in early childhood. Its clinical behavior is highly variable, ranging from spontaneous regression to fatal outcome despite intensive treatment. The International Society of Pediatric Oncology Europe Neuroblastoma Group (SIOPEN) Radiology and Nuclear Medicine Specialty Committees ...
Annemieke Littooij +11 more
wiley +1 more source
GATS tag system is compatible with biotin labelling methods for protein analysis
Scientific Reports, 2023 Polypeptide tags and biotin labelling technologies are widely used for protein analyses in biochemistry and cell biology. However, many peptide tag epitopes contain lysine residues (or amino acids) that are masked after biotinylation.
Kohdai Yamada +7 more
doaj +1 more source
Decentralizing Cell-Free RNA Sensing With the Use of Low-Cost Cell Extracts
Frontiers in Bioengineering and Biotechnology, 2021 Cell-free gene expression systems have emerged as a promising platform for field-deployed biosensing and diagnostics. When combined with programmable toehold switch-based RNA sensors, these systems can be used to detect arbitrary RNAs and freeze-dried ...
Anibal Arce +16 more
doaj +1 more source
Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya +10 more
wiley +1 more source